Tri-Conference 2008
会议概要 展销前置会 地点 参展/赞助 大会议程 询问 报名
会议将同时进行
Fluidigm
Thermo
Aviva Systems Biology
Biobase
Caprion Proteomics
Expression Analysis
Ingenuity
Scientia Advisors
Theranostics Health
Tripos
Wafer GEN
CROWNBIO
Leomics Associates
PCO
BioCentury
Bio IT World
SCIENCE AAAS
TheScienteist




Molecular Diagnostics 展销前置会

[  概要   |   展销前置会   |   1日目   |   2日目   |   3日目   |   Catalog(PDF)  ]

Tuesday, March 25

7:00am Registration (Open until 5:30pm)

PLENARY KEYNOTE SESSION

8:00 Plenary Keynote Introduction
Harry Glorikian, Managing Partner, Scientia Advisors

 

 

 

8:15 Diagnosing the Disease: Disruptive Innovation in Healthcare
Clayton M. Christensen, DBA, Robert and Jane Cizik Professor of Business Administration, Harvard Business School
In the absence of the ability to precisely define a disease, the care of patients isbest undertaken by highly skilled professionals, whose intuition is based on deep experience. This describes the history of health care, and we call this the practice of intuitive medicine. Molecular biology holds the promise of transforming medical practice into a new phase that we call precision medicine. It promises to dramatically reduce cost and increase the predictable effectiveness of therapy.

9:45 Coffee Break

10:15am 丒1:15pm Morning Pre-Conference Short Courses*

Recommended Short Course*

(SC1) BIOMARKERS ARE US: Interactive Short Course on How Biomarkers Will Impact the Field of Oncology
Jorge A. Le鏮, Ph.D., President, Leomics Consulting and Richard A. Bender, Medical Director, Hematology & Oncology, Quest Diagnostics Nichols Institute

  • What is a biomarker?

  • What does a biomarker have to comply with?

  • Where do they come from?

  • How do you validate a biomarker?

  • What is a good biomarker?

  • How do you implement?

  • Will it be reimbursed?

  • How do you market?

  • What are the next generation biomarkers?

  • Who are the industry players in this field?

  • Case studies in breast, lung, ovarian, bladder cancer

  • How to form alliances? 

*Separate Registration Required

1:15 Lunch on Your Own

2:30 - 5:30 Afternoon Pre-Conference Short Courses*

Recommended Short Course*

(SC6) CIRCULATING TUMOR CELLS 
This course will cover:

  • Biology and origin of CTCs

  • Development of CTC assays

  • Validation of CTC biomarkers

  • Design of clinical trials that incorporate CTCs

  • Use in predicting disease outcome and patient management

*Separate Registration Required

For a complete list of Short Courses, visit Tri-Conference.com

Catalog(PDF) Download
Schedule

语言选择